Lisa Ulrike Teufel

Ms. Lisa Ulrike Teufel


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Microbial Pathogenesis
Verified
Journal Article
Closed access
MSMuriel Vilela Teodoro Silva
Muriel Vilela Teodoro Silva
JSJéssica Cristina dos Santos
Jéssica Cristina dos Santos
AFAna Marina Barroso de Figueiredo
Ana Marina Barroso de Figueiredo
LTLisa Ulrike Teufel
Lisa Ulrike Teufel
JPJonathas Xavier Pereira
Jonathas Xavier Pereira
FRFátima Ribeiro-Dias
Fátima Ribeiro-Dias

Verified
Journal Article
Open access
PDF file
LTLisa Ulrike Teufel
Lisa Ulrike Teufel
MNMihai G. Netea
Mihai G. Netea
FVFrank van de Veerdonk
Frank van de Veerdonk
CDCharles A. Dinarello
Charles A. Dinarello
LJLeo A.B. Joosten
Leo A.B. Joosten
RARob J.W. Arts
Rob J.W. Arts
Trained immunity is the process of long-term functional reprogramming (a de facto innate immune memory) of innate immune cells such as monocytes and macrophages after an exposure to pathogens, vaccines, or their ligands. The induction of trained immunity is mediated through epigenetic and metabolic mechanisms. Apart from exogenous stimuli, trained immunity can be induced by endogenous compounds such as oxidized LDL, urate, fumarate, but also cytokines including IL-1α and IL-1β. Here, we show that also recombinant IL-36γ, a pro-inflammatory cytokine of the IL-1-family, is able to induce trained immunity in primary human monocytes, demonstrated by higher cytokine responses and an increase in cellular metabolic pathways both regulated by epigenetic histone modifications. These effects could be inhibited by the IL-36 receptor antagonist as well as by IL-38, an anti-inflammatory cytokine of the IL-1 family which shares its main receptor with IL-36 (IL-1R6). Further, we demonstrated that trained immunity induced by IL-36γ is mediated by NF-κB and mTOR signaling. The inhibitory effect of IL-38 on IL-36γ-induced trained immunity was confirmed in experiments using bone marrow of IL-38KO and WT mice. These results indicate that exposure to IL-36γ results in long-term pro-inflammatory changes in monocytes which can be inhibited by IL-38. Recombinant IL-38 could therefore potentially be used as a therapeutic intervention for diseases characterized by exacerbated trained immunity.

8 November 2019 in Hydrobiologia
Verified
Journal Article
Closed access
PDF file
WOWolfgang Ostendorp
Wolfgang Ostendorp
HHHilmar Hofmann
Hilmar Hofmann
LTLisa Ulrike Teufel
Lisa Ulrike Teufel
OMOliver Miler
Oliver Miler

18 June 2024 in Immunology Letters
Verified
Journal Article
Open access
LTLisa Ulrike Teufel
Lisa Ulrike Teufel
LJLeo A.B. Joosten
Leo A.B. Joosten
JSJéssica Cristina dos Santos
Jéssica Cristina dos Santos
Leishmaniasis is a collective term for several tropical, neglected diseases caused by protozoans of the species Leishmania, 20 of which causing disease in humans ranging from localised self-healing lesions to chronic manifestations which affect the skin or inner organs. Although millions of infections are accounted for annually, treatment options are scarce and limited to medication associated with heavy side-effects and increasing antibiotic resistance. Case studies point towards immunotherapy as effective alternative treatment relying on immunomodulatory properties of e.g., the Bacillus Calmette-Guérin vaccine. Leishmania parasites are also known to modulate the immune system, yet the underlying macromolecules and surface molecules remain widely under characterised. With this short review, we aim to provide a complete summary of the existing literature describing one of the most expressed surface molecule on Leishmania spp, lipophosphoglycan (LPG), which shows great variability between different lifecycle stages and different Leishmania spp. Complete characterisation of LPG may aid to improve treatment and aid the development of vaccination strategies, and open new avenues to exploit the immunomodulatory properties of LPG in unrelated conditions.

15 October 2025 in iScience
Verified
Journal Article
Open access
LTLisa Ulrike Teufel
Lisa Ulrike Teufel
VMVasiliki Matzaraki
Vasiliki Matzaraki
LFLukas Folkman
Lukas Folkman
DGDennis M. de Graaf
Dennis M. de Graaf
RHRob ter Horst
Rob ter Horst
RARob J.W. Arts
Rob J.W. Arts
Trained immunity is a long-lasting innate immune cell phenotype with benefits in infection control and recognized anti-cancer effects. Conversely, inappropriately induced trained immunity contributes to pathological inflammation, warranting the exploration of regulatory pathways. We explore interleukin-38 (IL-38) as a regulator of trained immunity in vivo in a cohort of 325 healthy adults vaccinated with Bacillus Calmette-Guérin (BCG). Using multi-omics profiling, we find that IL-38 is negatively associated with trained immunity on metabolic and epigenetic level. Genetic variants in IL1F10, encoding for IL-38, further link IL-38 to diminished training responses. These associations were validated in human and murine models. We confirmed that IL-38 functionally impairs anti-microbial traits of trained immunity in trained immunity-infection models in vivo (IL-38KO mice) and in vitro (human monocytes). Our study therefore suggests that IL-38 endogenously regulates the induction of trained immunity in humans in vivo.

4 December 2024 in STAR Protocols
Verified
Journal Article
Open access
LTLisa Ulrike Teufel
Lisa Ulrike Teufel
JSJéssica Cristina dos Santos
Jéssica Cristina dos Santos
Lipophosphoglycan (LPG) is a macromolecule on the surface of Leishmania spp. parasites. The biochemical structure of LPG varies throughout the parasites' life cycle between proliferative (procyclic) and infective (metacyclic) stages, as well as between species and strains. Here, we outline a protocol for growing Leishmania parasites in vitro to harvest LPG. We describe steps for parasite differentiation and LPG extraction and purification. LPG has applications in medical research, such as in trained immunity and immunotherapy for cancer. For complete details on the use and execution of this protocol, please refer to dos Santos et al.1.